Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
BeAble Capital
MadridSeed–Series A$162K – $2.2M
6 people
Crescent Capital
BelfastSeed–Series A$571.5K – $1.5M
6 people
ETCapital
CambridgeSeed–Series A$100K – $952.5K
3 people
Lifespan Vision Ventures
NorwalkPre-Seed–Series A
3 people
Militia Hill Ventures
PhiladelphiaSeed–Series A
9 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
LDV Partners
Palo AltoPre-Seed–Series A
11 people
Sugati Ventures
San RamonSeed–Series A
8 people
Device of Tomorrow Capital
Seed–Growth
2 people
BioTrack Capital
ShanghaiPre-Seed–Series A
7 people
BlueStone Venture Partners
TucsonSeed–Series B$250K – $1M
4 people
TRTL Ventures
SingaporeSeed–Series A
7 people
Snatched Ventures
San FranciscoSeed–Series A
2 people
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
3 people
BlueOcean Ventures
GenevaSeed–Series A$270K – $1.4M
6 people
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Growth
3 people
AZ Venture Capital Inc.
PhoenixPre-Seed–Series A
5 people
CARMA FUND
MunichPre-Seed–Series A
5 people
Front Row Fund
NewtownPre-Seed–Series A
8 people
Snickpick Investment
SeoulSeed–Series A
8 people
Kern Capital, LLC
LarkspurSeries A–Late Stage$5M – $15M
1 person
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
7 people
Rockies Venture Adviser, Llc
DenverPre-Seed–Series A$100K – $500K
7 people
Saffelberg Investments
GooikSeed–Late Stage
10 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.

































































